Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics of human gut T cells identifies cytotoxic CD4+CD8A+ T cells related to mouse CD4 cytotoxic T cells. | Front Immunol | 2022 | 36353619 | PubTator, text mining | PubMed |
| T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies. | Elife | 2022 | 36350695 | PubTator, text mining | PubMed |
| Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment. | Nat Commun | 2022 | 36347860 | PubTator, text mining | PubMed |
| NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes. | JCI Insight | 2022 | 36346670 | PubTator, text mining | PubMed |
| Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. | Front Oncol | 2022 | 36338705 | PubTator, text mining | PubMed |
| Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors. | Front Immunol | 2022 | 36330507 | PubTator, text mining | PubMed |
| speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. | Nat Commun | 2022 | 36323661 | PubTator, text mining | PubMed |
| Suppression of the malignancy of mammary tumor in mice model by inactivated preparation of Mycobacterium obuense. | Vet Res Forum | 2022 | 36320313 | PubTator, text mining | PubMed |
| NK cells and solid tumors: therapeutic potential and persisting obstacles. | Mol Cancer | 2022 | 36319998 | PubTator, text mining | PubMed |
| Connecting phenotype to genotype: PheWAS-inspired analysis of autism spectrum disorder. | Front Hum Neurosci | 2022 | 36310845 | PubTator, text mining | PubMed |
| Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. | Clin Transl Med | 2022 | 36305631 | PubTator, text mining | PubMed |
| Molecular Mechanisms of RSV and Air Pollution Interaction: A Scoping Review. | Int J Mol Sci | 2022 | 36293561 | PubTator, text mining | PubMed |
| Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. | Cancers (Basel) | 2022 | 36291830 | PubTator, text mining | PubMed |
| Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. | Nat Immunol | 2022 | 36289449 | PubTator, text mining | PubMed |
| Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates. | Front Immunol | 2022 | 36275702 | PubTator, text mining | PubMed |
| Strategies to overcome DC dysregulation in the tumor microenvironment. | Front Immunol | 2022 | 36275666 | PubTator, text mining | PubMed |
| STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer. | Cancer Res Commun | 2022 | 36275363 | PubTator, text mining | PubMed |
| Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles. | Cell Death Dis | 2022 | 36272970 | PubTator, text mining | PubMed |
| KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity. | Elife | 2022 | 36269050 | PubTator, text mining | PubMed |
| Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis. | J Oncol | 2022 | 36268282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=33